Resveratrol is a polyphenol compound found in various plants, including grape skins, peanut skins, and Japanese knotweed. Its discovery and study have a relatively recent history.
The first report of resveratrol was made in the 1940s by scientists studying the reason for the "French Paradox," which was the observation that the French had a low incidence of heart disease despite a diet high in saturated fat. They discovered that red wine, a staple of the French diet, contained high levels of resveratrol.
In the 1990s, studies in yeast and mice showed that resveratrol had potent antioxidant and anti-inflammatory properties, leading to further research into its potential health benefits. Since then, numerous studies have been conducted on resveratrol and its impact on various conditions.
While the “French Paradox” has been disproven now (sorry red wine lovers!), researcher David Sinclair out of Harvard has conducted some truly profound research on resveratrol’s anti-aging benefits through a pathway called SIRT1.
Similar to berberine, quercetin, and curcumin, the resveratrol compound is not bioavailable. This means that less than 1% of what you swallow passes through your gut barrier. As with our CurcElite, we solved this problem by attaching the resveratrol to a novel, organic carrier molecule.
Researching how much more bioavailable our ResverElite is has been difficult since. With curcumin, we were able to measure metabolites that came out in the urine to measure the bioavailability. Resveratrol, however, is quickly taken up into the tissues and bioaccumulates there, so it cannot be measured in urine.
In the coming weeks, I will share our functional research on blood glucose (which resveratrol lowers), Nrf-2 (which it upregulates), and Nf-kb (which it downregulates).
But for now, we are offering an introductory sale price: 12% off a one-time purchase and 25% off a subscription!